OUR LEADING PROGRAM

DNAe’s initial focus is on developing infectious disease diagnostics, where speed and DNA sequence information can make the difference between life and death. This includes a range of tests, starting with a groundbreaking test for bloodstream infections (BSI) and antimicrobial resistance (AMR), which uses whole blood specimens to detect and identify infections that lead to sepsis.

The diagnostic will rapidly identify what infection a patient has, as well as any associated antimicrobial resistance. This will provide clinicians with actionable information to help select the appropriate antibiotics to treat the disease.